Pluri Inc., also known as Pluri Biotech, is a pioneering biotechnology company headquartered in Illinois. Founded in 2016, Pluri has rapidly established itself in the regenerative medicine sector, focusing on innovative cell therapy solutions. The company is renowned for its unique PluriX™ technology, which enables the efficient production of pluripotent stem cells, setting a new standard in the industry. With a strong operational presence across North America and Europe, Pluri Inc. is committed to advancing therapeutic applications in areas such as drug discovery and personalised medicine. The company has achieved significant milestones, including collaborations with leading research institutions, solidifying its position as a key player in the biotechnology landscape. Pluri's dedication to quality and innovation continues to drive its success and influence in the regenerative medicine field.
How does Pluri Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Pluri Inc.'s score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pluri Inc., headquartered in Illinois, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Pluri Inc. may still be in the early stages of developing its climate commitments or may not have publicly disclosed its emissions profile. In the context of industry standards, it is essential for companies to establish clear carbon reduction targets and report their emissions transparently to align with global climate initiatives. Without specific emissions data or commitments, Pluri Inc. may face challenges in demonstrating its dedication to sustainability and climate action.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Pluri Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
